No effect of New Zealand blackcurrant extract on recovery of muscle damage following running a half-marathon

New Zealand blackcurrant (NZBC) contains anthocyanins, known to moderate blood flow and display anti-inflammatory properties that may improve recovery from exercise-induced muscle damage. The authors examined whether NZBC extract supplementation enhances recovery from exercise-induced muscle damage after a half-marathon race. Following a randomized, double-blind, independent groups design, 20 (eight women) recreational runners (age 30 ± 6 years, height 1.73 ± 0.74 m, body mass 68.5 ± 7.8 kg, half-marathon finishing time 1:56:33 ± 0:18:08 hr:min:s) ingested either two 300-mg/day capsules of NZBC extract (CurraNZ™) or a visually matched placebo, for 7 days prior to and 2 days following a half-marathon. Countermovement jump performance variables, urine interleukin-6, and perceived muscle soreness and fatigue were measured pre, post, and at 24 and 48 hr after the half-marathon and analyzed using a mixed linear model with statistical significance set a priori at p  .05). Urine interleukin-6 increased 48-hr post-half-marathon in the NZBC group only (p  .05). Perceived muscle soreness and fatigue increased immediately post-half-marathon (p  .05). Supplementation with NZBC extract had no effect on the recovery of countermovement jump variables and perceptions of muscle soreness or fatigue following a half-marathon in recreational runners

Effects of different dosages of caffeine administration on wrestling performance during a simulated tournament

The aim of the present study was to investigate the effects of different forms of caffeine administration on physical performance during a simulated wrestling tournament. In a double-blind and randomized experiment, twelve male freestyle wrestlers competed in a simulated wrestling tournament (5 wrestling matches consisting of 2×3-min wrestling rounds) following the ingestion of: a placebo, a high-dose of caffeine (10 mg/kg), a moderate-dose caffeine (4 mg/kg), a repeated-dose caffeine (2 mg/kg before each match to a total of 10 mg/kg) or a selective caffeine administration based on performance decrement previously measured (6.16±1.58 mg/kg). The Pittsburgh Wrestling Performance Test (PWPT) was measured before each match to assess physical performance. In comparison to the placebo, the high dose of caffeine only reduced PWPT time before the first match (56.8±2.0 vs. 52.9±1.8 s; p < 0.05). The moderate dose of caffeine did not affect PWPT performance during the tournament. Both, the repeated dose and the selective administration of caffeine reduced PWPT time with respect to the placebo in the third (66.7±1.8 vs. ~63.1±1.4 s; p < 0.05) and fourth matches (72.3±2.4 vs. ~65.9±1.3 s; p < 0.05). However, only the selective dose of caffeine reduced PWPT time before the fifth match (62.7±3.0 vs. 56.3±2.0; p < 0.05). The dosage and administration of caffeine affect the ergogenic effects obtained following the ingestion of this substance. An individualized protocol to provide caffeine when physical performance is expected to be reduced might improve wrestling performance during the latter stages of a tournament

Neuromuscular responses to mild-muscle damaging eccentric exercise in a low glycogen state.

The aim of this study was to examine the effect of low muscle glycogen on the neuromuscular responses to maximal eccentric contractions. Fourteen healthy men (22±3years) performed single-leg cycling (20min at ∼75% maximal oxygen uptake (V̇O2 max); eight 90 s sprints at a 1:1 work-to-rest ratio (5% decrements from 90% to 55% V̇O2 max until exhaustion) the evening before 100 eccentric (1.57rads(-1)) with reduced (RED) and normal glycogen (NORM). Neuromuscular responses were measured during and up to 48h after with maximal voluntary and involuntary (twitch, 20Hz and 50Hz) isometric contractions. During eccentric contractions, peak torque decreased (RED: -16.1±2.5%; NORM: -6.2±5.1%) and EMG frequency increased according to muscle length. EMG activity decreased for RED only. After eccentric contractions, maximal isometric force was reduced up to 24h for NORM (-13.5±5.8%) and 48h for RED (-7.4±10.9%). Twelve hours after eccentric contractions, twitch force and the 20:50Hz ratio were decreased for RED but not for NORM. Immediate involuntary with prolonged voluntary force loss suggests that reduced glycogen is associated with increased susceptibility to mild muscle-damaging eccentric exercise with contributions of peripheral and central mechanisms to be different during recovery

Dietary supplementation with New Zealand blackcurrant extract enhances fat oxidation during submaximal exercise in the heat

Objectives. This study investigated the effect of 7 days’ supplementation with New Zealand blackcurrant extract on thermoregulation and substrate metabolism during running in the heat. Design. Randomized, double-blind, cross-over study. Methods. Twelve men and six women (mean ± SD: Age 27 ± 6 years, height 1.76 ± 0.10 m, mass 74 ± 12 kg, V˙ O2max 53.4 ± 7.0 mL kg−1 min−1) completed one assessment of maximal aerobic capacity and one familiarisation trial (18 ◦C, 40% relative humidity, RH), before ingesting 2 × 300 mg day−1 capsules of CurraNZTM (each containing 105 mg anthocyanin) or a visually matched placebo (2 × 300 mg microcrystalline cellulose M102) for 7days (washout 14 days). On day 7 of each supplementation period, participants completed 60 min of fasted running at 65% V˙ O2max in hot ambient conditions (34 ◦C and 40% relative humidity). Results: Carbohydrate oxidation was decreased in the NZBC trial [by 0.24 g min−1 (95% CI: 0.21–0.27 g min-1)] compared to placebo (p = 0.014, d = 0.46), and fat oxidation was increased in the NZBC trial [by 0.12 g min−1 (95% CI: 0.10 to 0.15 g min−1)], compared to placebo (p = 0.008, d = 0.57). NZBC did not influence heart rate (p = 0.963), rectal temperature (p = 0.380), skin temperature (p = 0.955), body temperature (p = 0.214) or physiological strain index (p = 0.705) during exercise. Conclusions. Seven-days intake of 600 mg NZBC extract increased fat oxidation without influencing cardiorespiratory or thermoregulatory variables during prolonged moderate intensity running in hot conditions

Factors Associated with Revision Surgery after Internal Fixation of Hip Fractures

Background: Femoral neck fractures are associated with high rates of revision surgery after management with internal fixation. Using data from the Fixation using Alternative Implants for the Treatment of Hip fractures (FAITH) trial evaluating methods of internal fixation in patients with femoral neck fractures, we investigated associations between baseline and surgical factors and the need for revision surgery to promote healing, relieve pain, treat infection or improve function over 24 months postsurgery. Additionally, we investigated factors associated with (1) hardware removal and (2) implant exchange from cancellous screws (CS) or sliding hip screw (SHS) to total hip arthroplasty, hemiarthroplasty, or another internal fixation device. Methods: We identified 15 potential factors a priori that may be associated with revision surgery, 7 with hardware removal, and 14 with implant exchange. We used multivariable Cox proportional hazards analyses in our investigation. Results: Factors associated with increased risk of revision surgery included: female sex, [hazard ratio (HR) 1.79, 95% confidence interval (CI) 1.25-2.50; P = 0.001], higher body mass index (fo

Plasma uptake of selected phenolic acids following New Zealand blackcurrant extract supplementation in humans

New Zealand blackcurrant (NZBC) extract is a rich source of anthocyanins and in order to exert physiological effects, the anthocyanin-derived metabolites need to be bioavailable in vivo. We examined the plasma uptake of selected phenolic acids following NZBC extract supplementation alongside maintaining a habitual diet (i.e. not restricting habitual polyphenol intake). Twenty healthy volunteers (nine females, age: 28 ± 7 years, height 1.73 ± 0.09 m, body mass 73 ± 11 kg) consumed a 300 mg NZBC extract capsule (CurraNZ®; anthocyanin content 105 mg) following an overnight fast. Venous blood samples were taken pre and 1, 1.5, 2, 3, 4, 5, and 6 h post-ingestion of the capsule. Reversed-phase high-performance liquid chromatography (HPLC) was used for analysis of two dihydroxybenzoic acids [i.e. vanillic acid (VA) and protocatechuic acid (PCA)] and one trihydroxybenzoic acid [i.e. gallic acid (GA)] in plasma following NZBC extract supplementation. Habitual anthocyanin intake was 168 (95%CI:68–404) mg⋅day−1 and no associations were observed between this and VA, PCA, and GA plasma uptake by the NZBC extract intake. Plasma time-concentration curves revealed that GA, and PCA were most abundant at 4, and 1.5 h post-ingestion, representing a 261% and 320% increase above baseline, respectively, with VA remaining unchanged. This is the first study to demonstrate that an NZBC extract supplement increases the plasma uptake of phenolic acids GA, and PCA even when a habitual diet is followed in the days preceding the experimental trial, although inter-individual variability is apparent

Anthocyanin-Rich Blackcurrant Extract Preserves Gastrointestinal Barrier Permeability and Reduces Enterocyte Damage but Has No Effect on Microbial Translocation and Inflammation After Exertional Heat Stress

This study investigated the effects of 7 days of 600 mg/day anthocyanin-rich blackcurrant extract intake on small intestinal permeability, enterocyte damage, microbial translocation and inflammation following exertional heat stress. Twelve recreationally active men (maximal aerobic capacity = 55.6 ± 6.0 mL.kg-1.min-1) ran (70% VO2max) for 60 minutes in an environmental chamber (34°C, 40% relative humidity) on two occasions (Placebo/Blackcurrant, randomized double-blind cross over). Permeability was assessed from a 4-hour urinary excretion of lactulose (L) and rhamnose (R) and expressed as a ratio of L/R. Venous blood samples were taken at rest and 20, 60 and 240 min after exercise to measure enterocyte damage (intestinal fatty acid binding protein, I-FABP), microbial translocation (sCD14; lipopolysaccharide binding protein, LBP), and interleukins 6 (IL-6), 10 (IL-10) and 1 receptor antagonist (IL-1RA). Exercise increased rectal temperature (by ~2.8 °C) and heart rate (by ~123 beats.min-1) in each condition. Blackcurrant supplementation led to a) ~12% reduction in L/R ratio (p<0.0034) and enterocyte damage (~40% reduction in I-FABP area under the curve, AUC; p<0.0001) relative to placebo. No between condition differences were observed immediately after exercise for LBP (+80%, +61 to +99%; mean, 95% confidence interval), sCD14 (+37%, +22 to +51%), IL-6 (+494%, +394 to +690%), IL-10 (+288%, +105 to +470%) or IL-1RA (+47%, +13 to +80; all time main effects). No between-condition differences for these markers were observed after 60 or 240 min of recovery. Blackcurrant extract preserves the GI barrier, however at sub-clinical levels this had no effect on microbial translocation and downstream inflammatory processes

Reproducibility of lactate markers during 4 and 8 min stage incremental running: A pilot study

OBJECTIVES: This study examined the reproducibility of speed corresponding to specific lactate markers during incremental treadmill running of normal and prolonged stage durations. DESIGN: Nineteen healthy participants (14 male, 5 female) performed repeated, incremental treadmill running trials of 4 and 8 min stages on separate days to examine the test-retest reproducibility of speed at lactate markers. Two trials were completed for each duration in a randomised order. METHODS: Fingertip blood samples drawn upon stage completion were analysed for plasma lactate, then used to determine running speed at: 2.0, 3.5, and 4.0 mmol l(-1) fixed blood lactate accumulations (FBLA), a 1 mmol l(-1) rise from baseline, and the markers: the deviation maximum (Dmax), the Dmax of the second curve derivative (D2L(max)), the lactate threshold (LT) and log-log LT. RESULTS: The 2.0 mmol l(-1) FBLA reported the lowest mean bias between 4 min trials (-0.06 km h(-1)), with the narrowest limits of agreement (LoA) (-1.78 to 1.66 km h(-1)). The Dmax had the second lowest bias (0.14 km h(-1)), D2L(max) the second narrowest LoA (-1.93 to 2.90 km h(-1)). For 8 min stages, the 1 mmol l(-1) rise demonstrated, low mean bias (-0.13 km h(-1)) and narrowest LoA (-1.22 to 0.97 km h(-1)) between trials. CONCLUSIONS: This preliminary report suggests the reproducibility of running speed at lactate summary markers is influenced by stage duration for incremental treadmill running. Varied marker reproducibility between 4 and 8 min stages indicates different blood lactate response, and therefore workload calculation, according to stage length. Consideration of marker construct is recommended